Morning Movers (GTXI, PBY, TNB, CTIC, PMC)

After the first half-hour of trading, GTX Inc. is up more than 30% at $5.15. Volume is about 8x the daily average of about 188,000 shares traded. The drug maker’s shares have been given a new price target of $19/share from Citigroup.

Pep Boys is up nearly 23% at $14.85 after posting a new 52-week high of $15.00 earlier. Volume is already more than 13x the daily average of about 500,000 shares traded. The auto parts retailer has agreed to an acquisition at $15/share. See more of our coverage here.

Thomas & Betts is up more than 22% at $71.00 after posting a new 52-week high of $71.30 earlier. Volume is already 20x the daily average of about 330,000 shares traded. The electrical components maker has agreed to an acquisition by ABB Ltd. for $3.9 billion.

Cell Therapeutics is down nearly -17% at $1.11. Volume already more than double the daily average of 1.8 million shares traded. The drug maker has withdrawn its application with FDA for approval of its non-Hodgkin’s lymphoma treatment.

Pharmerica is down nearly -13% at $12.49. Volume is already more than double the daily average of nearly 400,000 shares traded. The pharmacy services provider has expressed its wish that a hostile takeover bid from Omnicare Inc. (NYSE: OCR) will be withdrawn, following a Federal Trade Commission suit to block the deal. More coverage here.

Paul Ausick